重症腹腔脓毒症患者持续输注两性霉素B的肾毒性:倾向评分匹配回顾性分析
本研究在荷兰两家大型教学医院混合内外科ICU中回顾性纳入2006至2019年腹腔脓毒症患者319例(185例接受持续输注传统两性霉素B(CCAB)且以治疗药物监测(TDM)指导剂量,134例对照)。多元线性回归及倾向评分匹配(134对)分析均显示CCAB治疗及累积剂量与血清肌酐浓度无关,提示TDM指导的CCAB未导致肾功能损害。
要点
- TDM指导的CCAB未导致重症腹腔脓毒症患者肾功能损害。
- 倾向评分匹配后累积CCAB剂量与血清肌酐浓度无关联。
- 研究排除CCAB治疗不足72小时及接受肾脏替代治疗者。
核心结论
- 在重症腹腔脓毒症患者中,以TDM指导的持续输注传统两性霉素B未导致随时间进展的肾功能损害。
研究设计与样本
- 回顾性分析,荷兰两家大型教学医院混合内外科ICU,2006至2019年连续纳入腹腔脓毒症患者,比较接受与未接受CCAB治疗者。
- 共纳入319例患者,其中185例接受CCAB治疗,134例对照;CCAB剂量由TDM指导。
- 排除CCAB治疗不足72小时者及接受肾脏替代治疗者。
- 采用多元线性回归及倾向评分匹配(134对)分析。
主要发现
- 多元线性回归模型显示血清肌酐浓度与CCAB治疗无关(β = -0.023;95% CI = -12.2 to 7.2;P = 0.615)。
- 倾向评分匹配后134对分析显示累积CCAB剂量与ICU治疗期间血清肌酐浓度无关(β = 0.299;95% CI = -0.38 to 0.98;P = 0.388)。
临床怎么用
- 对重症腹腔脓毒症患者,可考虑在TDM指导下使用持续输注传统两性霉素B进行侵袭性真菌感染的抢先治疗,无需因担忧肾毒性而避免。
局限性
- 回顾性研究设计。
- 单国两家医院数据,外推性受限。
- 排除CCAB治疗不足72小时及接受肾脏替代治疗者,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Continuous infusion of conventional amphotericin B (CCAB) is used in ICUs for pre-emptive treatment of invasive fungal infections. Amphotericin B has previously been associated with nephrotoxicity. OBJECTIVES: To investigate if CCAB with therapeutic drug monitoring (TDM) results in renal impairment over time in critically ill patients with abdominal sepsis. PATIENTS AND METHODS: The study was conducted at mixed medical-surgical ICUs of two large teaching hospitals in the Netherlands. Consecutive patients who were treated on the ICUs between 2006 and 2019 for abdominal sepsis, with or without CCAB, were included. CCAB dosing was guided by TDM. Serum creatinine concentrations and renal failure scores of patients with CCAB treatment were compared with those without CCAB treatment. Excluded were: (i) patients treated with CCAB for less than 72 h; and (ii) patients with renal replacement therapy. RESULTS: A total of 319 patients were included (185 treated with CCAB and 134 controls). A multiple linear regression model showed that the serum creatinine concentration was independent of CCAB treatment (β = -0.023; 95% CI = -12.2 to 7.2; P = 0.615). Propensity score matching resulted in 134 pairs of CCAB-treated and non-treated patients. Again, the analysis of these pairs showed that the cumulative CCAB dose was not associated with serum creatinine concentration during intensive care treatment (β = 0.299; 95% CI = -0.38 to 0.98; P = 0.388). CONCLUSIONS: CCAB with TDM did not result in renal impairment over time in critically ill patients with abdominal sepsis.
引用
- Geersing TH, Franssen EJF, Spronk PE, et al. Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching. J Antimicrob Chemother. 2021. PMID: 34613383. doi:10.1093/jac/dkab372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。